# Efficacy and Safety of AN2898 and AN2728 Topical Ointments to Treat Mild-to-Moderate Atopic Dermatitis

> **NCT01301508** · PHASE2 · COMPLETED · sponsor: **Pfizer** · enrollment: 46 (actual)

## Conditions studied

- Dermatitis, Atopic

## Interventions

- **DRUG:** AN2728 ointment, 2%
- **DRUG:** AN2898 ointment, 1%
- **DRUG:** AN2898 ointment vehicle
- **DRUG:** AN2728 ointment vehicle

## Key facts

- **NCT ID:** NCT01301508
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-05
- **Primary completion:** 2011-11-11
- **Final completion:** 2011-11-11
- **Target enrollment:** 46 (ACTUAL)
- **Last updated:** 2019-02-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01301508

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01301508, "Efficacy and Safety of AN2898 and AN2728 Topical Ointments to Treat Mild-to-Moderate Atopic Dermatitis". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01301508. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*